Durham medical imaging company names new CEO
Polarean, a provider of medical imaging technology, has a new CEO – industry veteran Dr. Christopher von Jako. He replaces Richard Hullihen, who is retiring.
Read More
polarean
Bringing MRIs into sharper focus: Durham firm secures FDA approval for drug-and-device combo
Polarean Imaging, a Durham-based medical imaging technology company, has received regulatory clearance for a drug and device combination product that helps doctors visualize lung function in patients with chronic lung disease.
Read More
Duke spinout Polarean files NDA for lung diagnostic, possible COVID-19 aid
Its CEO Richard Hullihen said the system could potentially reach millions of patients in need of a novel tool to better understand their lung disease – including those suffering from the lingering effects of COVID-19.
Read More
Duke spinout Polarean exceeds expectations with lung-imaging trial, seeks meeting with FDA
The company says its clinical importance is in its ability to improve images of patients’ lung function and capacity using a whiff of a harmless gas called hyperpolarized 129Xenon during magnetic resonance imaging (MRI). The Polarean method then uses three-dimensional mapping to monitor respiratory function.
Read More
Durham MRI tech firm with Duke ties is raising $4M
Polarean Imaging, which operates a facility in Durham, is set to raise an additional $4 million in a conditional placing led by the broker Northland Capital Partners Limited.
Read More
